Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 Jan;50(1):3–5. doi: 10.1136/thx.50.1.3

Opportunities for diagnosing cytomegalovirus in pulmonary infections.

D J Morris
PMCID: PMC473694  PMID: 7886645

Full text

PDF
3

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chou S. W., Scott K. M. Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients. J Clin Microbiol. 1988 Oct;26(10):2116–2119. doi: 10.1128/jcm.26.10.2116-2119.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dahmen U., Qian S., Rao A. S., Demetris A. J., Fu F., Sun H., Gao L., Fung J. J., Starzl T. E. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15;58(1):1–8. doi: 10.1097/00007890-199407000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dyer P. A., Johnson R. W., Martin S., Bakran A., Gokal R., Harris R., Mallick N. P., Manos J., Orr W. M., Pearson R. C. Evidence that matching for HLA antigens significantly increases transplant survival in 1001 renal transplants performed in the northwest region of England. Transplantation. 1989 Jul;48(1):131–135. doi: 10.1097/00007890-198907000-00030. [DOI] [PubMed] [Google Scholar]
  4. Egan J. J., Barber L., Lomax J., Fox A., Yonan N., Rahman A. N., Campbell C. S., Deiraniya A. K., Carroll K. B., Craske J. Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax. 1995 Jan;50(1):9–13. doi: 10.1136/thx.50.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Erice A., Chou S., Biron K. K., Stanat S. C., Balfour H. H., Jr, Jordan M. C. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med. 1989 Feb 2;320(5):289–293. doi: 10.1056/NEJM198902023200505. [DOI] [PubMed] [Google Scholar]
  6. Griffiths P. D., Panjwani D. D., Stirk P. R., Ball M. G., Ganczakowski M., Blacklock H. A., Prentice H. G. Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet. 1984 Dec 1;2(8414):1242–1245. doi: 10.1016/s0140-6736(84)92797-1. [DOI] [PubMed] [Google Scholar]
  7. Grundy J. E., Shanley J. D., Griffiths P. D. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet. 1987 Oct 31;2(8566):996–999. doi: 10.1016/s0140-6736(87)92560-8. [DOI] [PubMed] [Google Scholar]
  8. Khaghani A., Yacoub M., McCloskey D., Awad J., Burden M., Fitzgerald M., Hawes R., Holmes J., Smith J., Banner N. The influence of HLA matching, donor/recipient sex, and incidence of acute rejection on survival in cardiac allograft recipients receiving cyclosporin A and azathioprine. Transplant Proc. 1989 Feb;21(1 Pt 1):799–800. [PubMed] [Google Scholar]
  9. Kidd I. M., Fox J. C., Pillay D., Charman H., Griffiths P. D., Emery V. C. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation. 1993 Oct;56(4):867–871. doi: 10.1097/00007890-199310000-00018. [DOI] [PubMed] [Google Scholar]
  10. Kimpton C. P., Corbitt G., Morris D. J. Detection of cytomegalovirus DNA using probes labelled with digoxigenin. J Virol Methods. 1989 Jun;24(3):335–346. doi: 10.1016/0166-0934(89)90046-3. [DOI] [PubMed] [Google Scholar]
  11. Morris D. J. Adverse effects and drug interactions of clinical importance with antiviral drugs. Drug Saf. 1994 Apr;10(4):281–291. doi: 10.2165/00002018-199410040-00002. [DOI] [PubMed] [Google Scholar]
  12. Morris D. J. Antiviral chemoprophylaxis for cytomegalovirus infection. J Antimicrob Chemother. 1988 Oct;22(4):569–569. doi: 10.1093/jac/22.4.569. [DOI] [PubMed] [Google Scholar]
  13. Morris D. J. Antiviral chemotherapy for cytomegalovirus disease. J Antimicrob Chemother. 1988 May;21(5):519–522. doi: 10.1093/jac/21.5.519. [DOI] [PubMed] [Google Scholar]
  14. Morris D. J. Cytomegalovirus pneumonia--a consequence of immunosuppression and pre-existing lung damage rather than immunopathology? Respir Med. 1993 Jul;87(5):345–349. doi: 10.1016/0954-6111(93)90047-4. [DOI] [PubMed] [Google Scholar]
  15. Morris D. J. Cytomegalovirus pneumonia--a consequence of immunosuppression and pre-existing lung damage rather than immunopathology? Respir Med. 1993 Jul;87(5):345–349. doi: 10.1016/0954-6111(93)90047-4. [DOI] [PubMed] [Google Scholar]
  16. Morris D. J. Ganciclovir and immune globulin in cytomegalovirus pneumonia. Ann Intern Med. 1989 Apr 1;110(7):575–575. doi: 10.7326/0003-4819-110-7-575_1. [DOI] [PubMed] [Google Scholar]
  17. Morris D. J., Kimptoh C. P., Corbitt G. Persistence of cytomegalovirus in peripheral blood from blood donors. BMJ. 1989 Nov 4;299(6708):1164–1165. doi: 10.1136/bmj.299.6708.1164-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morris D. J., Klapper P. E., Crosdale E., White J. Screening of bone marrow and kidney transplant donors and recipients for cytomegalovirus antibody by commercial latex agglutination or competitive enzyme-linked immunosorbent assays. J Virol Methods. 1990 Dec;30(3):339–342. doi: 10.1016/0166-0934(90)90077-s. [DOI] [PubMed] [Google Scholar]
  19. Morris D. J., Longson M. Laboratory diagnosis of simultaneous cytomegalovirus and herpes simplex virus infection. J Infect. 1988 May;16(3):309–310. doi: 10.1016/s0163-4453(88)97844-9. [DOI] [PubMed] [Google Scholar]
  20. Morris D. J., Longson M., Poslethwaite R. J., Mallick N. P., Johnson R. W. Donor seropositivity and prednisolone therapy as risk factors for cytomegalovirus infection and disease in cyclosporin-treated renal allograft recipients. Q J Med. 1990 Nov;77(283):1165–1173. doi: 10.1093/qjmed/77.2.1165. [DOI] [PubMed] [Google Scholar]
  21. Morris D. J., Martin S., Dyer P. A., Hunt L., Mallick N. P., Johnson R. W. HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients. J Med Virol. 1993 Dec;41(4):324–327. doi: 10.1002/jmv.1890410413. [DOI] [PubMed] [Google Scholar]
  22. Prentice H. G., Gluckman E., Powles R. L., Ljungman P., Milpied N., Fernandez Rañada J. M., Mandelli F., Kho P., Kennedy L., Bell A. R. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet. 1994 Mar 26;343(8900):749–753. doi: 10.1016/s0140-6736(94)91835-x. [DOI] [PubMed] [Google Scholar]
  23. Schmidt G. M., Horak D. A., Niland J. C., Duncan S. R., Forman S. J., Zaia J. A. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Engl J Med. 1991 Apr 11;324(15):1005–1011. doi: 10.1056/NEJM199104113241501. [DOI] [PubMed] [Google Scholar]
  24. Williams P. F., Wreghitt T., Joysey V., Evans D. B., Calne R. Y. Cytomegalovirus matching in renal transplantation. Lancet. 1988 Sep 3;2(8610):569–569. doi: 10.1016/s0140-6736(88)92691-8. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES